Abstracts (HTML) List of Authors

Jaeckel, E

Diagnostic algorithm to detect NASH and fibrosis in NAFLD patients with low NAFLD fibrosis score or liver stiffness
Growth differentiation factor 11 mitigates liver fibrosis via expansion of liver progenitor cells

Jäger, J

SEAL program – Early detection of liver fibrosis and cirrhosis by screening of the general population

Jahn, D

Glucose and metformin differentially regulate FGF19 signaling in human HepG2 cells

Jäkel, J

Cis-E:N-Cadherin-Heterodimere als Charakteristikum von Tumoren des hepatopankreatobiliären Systems

Janciauskiene, S

Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)
Die Therapie mit Alpha-1-Antitrypsin (AAT) assoziiert bei AAT-Mangel mit besseren Leber-bezogenen Parametern

Janoschek, R

Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming

Jansen, C

Low muscle mass and large portosystemic shunt in “one-stop shop” CT exponentially increases risk for HE and mortality
Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure

Janssen, H

Loss of Sirtuin6 induces expression of the cancer-related transmembrane protein TMEM45A in HepG2 cells

Javaheri-Haghighi, B

Intestinal deletion of fatty acid transport protein 4 in mice increases blood chylomicrons

Jechow, K

Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal

Jöchle, K

Impact of complexity of laparoscopic liver resections on postoperative complications

Johannssen, T

Expanded primary human liver sinusoidal endothelial cells as a tool for complex hepatotoxicity studies

Johansen, P

A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control

John, C

Real-world efficacy of EBR/GZR in HCV GT1 patients with multiple comorbidities and medications: results from the DHC-R
Real-world efficacy of elbasvir/grazoprevir in HCV GT1 infected diabetics: results from the German Hepatitis C Registry

Jonigk, D

Pulmonary arterial hypertension leads to liver fibrosis in the SU5416/hypoxia model in rats

Jördens, M

Effect of HE-relevant factors on GLAST clustering in cultured rat astrocytes

Jörg, R

Metabolic reprogramming in livers of mice with chronic liver disease

Juárez Martín-Delgado, I

Shedding light on BASH: A novel experimental model of advanced liver damage

Jung, C

Real-life efficacy and safety profile of TACE in patients with intermediate HCC in a large German cohort
Retrospective evaluation of RFA and MWA for the treatment of HCC at the University Medical Center Hamburg 2008 – 2016
Improvement in median OS in patients with advanced HCC and strict eligibility criteria receiving Sorafenib

Jungmann, F

Survival prediction for patients with ICC undergoing chemotherapy: comparing tumor markers to cross-sectional imaging